2022 Archive Requests for Applications (RFA's) |
RFA No. and Title | Status - Expiration |
---|
CA22-057 Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed) | EXPIRED - DEC 16, 2023 |
CA22-056 Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed) | EXPIRED - DEC 16, 2023 |
CA22-055 Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed) | EXPIRED - NOV 22, 2022 |
CA22-054 The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional) | EXPIRED - SEP 20, 2022 |
CA22-053 Coordinating Center for Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U24 Clinical Trial Not Allowed) | EXPIRED - FEB 18, 2023 |
CA22-052 Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U01 Clinical Trial Not Allowed) | EXPIRED - FEB 18, 2023 |
CA22-051 Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) | EXPIRED - DEC 29, 2022 |
CA22-050 NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional) | EXPIRED - FEB 07, 2024 |
CA22-046 Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required) | EXPIRED - OCT 04, 2022 |
CA22-043 Advancing Adolescent Tobacco Cessation Intervention Research (R01 Clinical Trial Required) | EXPIRED - OCT 17, 2023 |
CA22-042 Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional) | EXPIRED - OCT 17, 2023 |
CA22-041 The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) | EXPIRED - NOV 19, 2022 |
CA22-040 The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed) | EXPIRED - SEP 09, 2022 |
CA22-039 The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional) | EXPIRED - SEP 09, 2022 |
CA22-038 Limited Competition: Cancer Immune Monitoring and Analysis Centers (CIMACs) and Cancer Immunologic Data Center (CIDC) (U24 Clinical Trial Not Allowed) | EXPIRED - OCT 25, 2022 |
CA22-037 NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) | EXPIRED - MAR 01, 2023 |
CA22-036 NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) | EXPIRED - MAR 01, 2023 |
CA22-035 NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) | EXPIRED - MAR 01, 2023 |
CA22-032 Consortium on Translational Research in Early Detection of Liver Cancer: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed) | EXPIRED - NOV 08, 2022 |
CA22-031 Consortium on Translational Research in Early Detection of Liver Cancer: Translational Research Centers (U01 Clinical Trial Optional) | EXPIRED - NOV 08, 2022 |
CA22-030 Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed) | EXPIRED - OCT 29, 2022 |
CA22-029 Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required) | EXPIRED - JUL 01, 2023 |
CA22-028 Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required) | EXPIRED - JUL 01, 2023 |
CA22-027 Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional) | EXPIRED - SEP 30, 2023 |
CA22-026 Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed) | EXPIRED - SEP 16, 2022 |
CA22-025 SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) | EXPIRED - AUG 06, 2022 |
CA22-024 Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | EXPIRED - NOV 18, 2022 |
CA22-023 Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | EXPIRED - NOV 18, 2022 |
CA22-022 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) | EXPIRED - NOV 18, 2022 |
CA22-021 Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) | EXPIRED - NOV 18, 2022 |
CA22-020 Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) | EXPIRED - JUN 18, 2022 |
CA22-019 Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional) | EXPIRED - NOV 09, 2022 |
CA22-017 Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) | EXPIRED - AUG 23, 2022 |
CA22-016 Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional) | EXPIRED - SEP 28, 2022 |
CA22-015 Cancer Control Research in Persistent Poverty Areas (U54 Clinical Trial Optional) | EXPIRED - JUL 07, 2022 |
CA22-014 Data, Evaluation and Coordinating Center for: A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) (U24 Clinical Trial Not Allowed) | EXPIRED - MAR 29, 2022 |
CA22-013 PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed) | EXPIRED - NOV 02, 2022 |
CA22-012 Patient Derived Xenograft (PDX) Development and Trial Centers (PDTCs) Network (U54 Clinical Trial Not Allowed) | EXPIRED - NOV 02, 2022 |
CA22-011 U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional) | EXPIRED - MAR 31, 2022 |
CA22-010 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) | EXPIRED - SEP 23, 2022 |
CA22-009 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) | EXPIRED - SEP 23, 2022 |
CA22-008 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) | EXPIRED - SEP 23, 2022 |
CA22-007 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) | EXPIRED - SEP 23, 2022 |
CA22-006 Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) | EXPIRED - SEP 23, 2022 |
CA22-005 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) | EXPIRED - SEP 23, 2022 |
CA22-004 Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | EXPIRED - SEP 23, 2022 |
CA22-003 Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | EXPIRED - SEP 23, 2022 |
CA22-002 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | EXPIRED - SEP 23, 2022 |
CA22-001 Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | EXPIRED - SEP 23, 2022 |
2021 Archive Requests for Applications (RFA's) |
RFA No. and Title | Status - Expiration |
---|
CA21-063 A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Optional) | EXPIRED - DEC 11, 2021 |
CA21-062 NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) | EXPIRED - MAR 01, 2022 |
CA21-061 NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) | EXPIRED - MAR 01, 2022 |
CA21-060 NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) | EXPIRED - MAR 01, 2022 |
CA21-059 The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) | EXPIRED - NOV 19, 2021 |
CA21-058 Data, Evaluation and Coordinating Center for: A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) (U24 Clinical Trial Not Allowed) | EXPIRED - NOV 20, 2021 |
CA21-057 A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT U01 Clinical Trial Not Allowed) | EXPIRED - NOV 20, 2021 |
CA21-056 Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional) | EXPIRED - DEC 16, 2021 |
CA21-055 Translational and Basic Science Research in Early Lesions (TBEL) Coordinating and Data Management Center (U24 Clinical Trial Not Allowed) | EXPIRED - NOV 03, 2021 |
CA21-054 Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed) | EXPIRED - NOV 03, 2021 |
CA21-053 Coordinating and Data Management Center for Acquired Resistance to Therapy Network (ARTNet; U24 Clinical Trial Not Allowed) | EXPIRED - NOV 02, 2021 |
CA21-052 Acquired Resistance to Therapy Network (ARTNet; U54 Clinical Trial Not Allowed) | EXPIRED - NOV 02, 2021 |
CA21-051 Coordinating Center for Canine Cancer Immunotherapy Network (K9CIN; U24 Clinical Trial Not Allowed) | EXPIRED - SEP 28, 2021 |
CA21-050 Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed) | EXPIRED - SEP 28, 2021 |
CA21-049 Division of Cancer Biology Multi-Consortia Coordinating Center (U24 Clinical Trial Not Allowed) | EXPIRED - NOV 13, 2021 |
CA21-048 Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed) | EXPIRED - OCT 20, 2022 |
CA21-047 Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) | EXPIRED - DEC 29, 2021 |
CA21-046 Research Bases for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) | EXPIRED - DEC 29, 2021 |
CA21-045 Coordinating Center for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (U24 Clinical Trial Required) | EXPIRED - DEC 29, 2021 |
CA21-042 Pancreatic Ductal Adenocarcinoma Stromal Reprogramming Consortium Coordinating and Data Management Center (PSRC CDMC) (U24 Clinical Trial Not Allowed) | EXPIRED - NOV 02, 2021 |
CA21-041 Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 Clinical Trial Not Allowed) | EXPIRED - NOV 02, 2021 |
CA21-040 Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required) | EXPIRED - NOV 02, 2021 |
CA21-039 Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) (U24 Clinical Trial Not Allowed) | EXPIRED - OCT 08, 2021 |
CA21-038 Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed) | EXPIRED - OCT 08, 2021 |
CA21-037 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed) | EXPIRED - NOV 23, 2021 |
CA21-036 SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) | EXPIRED - AUG 07, 2021 |
CA21-035 The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed) | EXPIRED - SEP 10, 2021 |
CA21-034 The Early Detection Research Network: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed) | EXPIRED - SEP 10, 2021 |
CA21-033 The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional) | EXPIRED - SEP 10, 2021 |
CA21-032 Coordinating Center for Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U24 Clinical Trial Not Allowed) | EXPIRED - JUL 15, 2021 |
CA21-031 Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U01 Clinical Trial Required) | EXPIRED - JUL 15, 2021 |
CA21-030 Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) | EXPIRED - JUN 03, 2021 |
CA21-029 Centers on Telehealth Research for Cancer Related Care (P50 Clinical Trial Required) | EXPIRED - JUL 21, 2021 |
CA21-027 Coordinating Center for the Program on the Origins of Gastroesophageal Cancers (U24 Clinical Trial Not Allowed) | EXPIRED - OCT 09, 2021 |
CA21-026 Program on the Origins of Gastroesophageal Cancers (R01 Clinical Trial Optional) | EXPIRED - OCT 09, 2021 |
CA21-025 Proteogenomic Translational Research Centers (PTRCs) for Clinical Proteomic Tumor Analysis Consortium (U01 Clinical Trial Not Allowed) | EXPIRED - JUL 31, 2021 |
CA21-024 Proteogenomic Data Analysis Centers (PGDACs) for Clinical Proteomic Tumor Analysis Consortium (U24 Clinical Trial Not Allowed) | EXPIRED - JUL 01, 2021 |
CA21-023 Proteome Characterization Centers (PCCs) for Clinical Proteomic Tumor Analysis Consortium (U24 Clinical Trial Not Allowed) | EXPIRED - JUL 01, 2021 |
CA21-022 Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: A Transdisciplinary Approach to Obesity-Associated Cancer Research (U24 Clinical Trial Not Allowed) | EXPIRED - OCT 07, 2021 |
CA21-021 Metabolic Dysregulation and Cancer Risk Program, Research Grants: a Transdisciplinary Approach to Obesity-Associated Research (U01 Clinical Trial Optional) | EXPIRED - OCT 07, 2021 |
CA21-020 National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed) | EXPIRED - SEP 29, 2023 |
CA21-019 Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional) | EXPIRED - NOV 19, 2021 |
CA21-018 Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional) | EXPIRED - NOV 18, 2021 |
CA21-017 Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional) | EXPIRED - NOV 18, 2021 |
CA21-016 Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | EXPIRED - NOV 18, 2021 |
CA21-015 Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | EXPIRED - NOV 18, 2021 |
CA21-014 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) | EXPIRED - NOV 18, 2021 |
CA21-013 Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) | EXPIRED - NOV 18, 2021 |
CA21-012 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) | EXPIRED - SEP 30, 2021 |
CA21-011 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) | EXPIRED - SEP 30, 2021 |
CA21-010 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) | EXPIRED - SEP 30, 2021 |
CA21-009 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional) | EXPIRED - SEP 30, 2021 |
CA21-008 Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) | EXPIRED - SEP 30, 2021 |
CA21-007 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) | EXPIRED - SEP 30, 2021 |
CA21-006 Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | EXPIRED - SEP 30, 2021 |
CA21-005 Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) | EXPIRED - SEP 30, 2021 |
CA21-004 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | EXPIRED - SEP 29, 2021 |
CA21-003 Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) | EXPIRED - SEP 30, 2021 |